miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways

Published:1 March 2022 DOI: 10.1016/j.omtn.2022.03.020

Guoshu Bi,?Jiaqi Liang,?Mengnan Zhao,?Huan Zhang,?Xing Jin,?T. Lu,?Yuansheng Zheng,?Yunyi Bian,?Zhencong Chen,?Yiwei Huang,?Valeria Besskaya,?C. Zhan,?Qun Wang,?L. Tan

Abstract